| Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties JH Taube, GG Malouf, E Lu, N Sphyris, V Vijay, PP Ramachandran, ... Scientific reports 3 (1), 2687, 2013 | 144 | 2013 |
| Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy S Gaur, Y Wen, JH Song, NU Parikh, LS Mangala, AM Blessing, C Ivan, ... Oncotarget 6 (30), 29161, 2015 | 117 | 2015 |
| The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials A Varkaris, PG Corn, S Gaur, F Dayyani, CJ Logothetis, GE Gallick Expert opinion on investigational drugs 20 (12), 1677-1684, 2011 | 92 | 2011 |
| Ligand‐independent activation of MET through IGF‐1/IGF‐1R signaling A Varkaris, S Gaur, NU Parikh, JH Song, F Dayyani, JK Jin, CJ Logothetis, ... International journal of cancer 133 (7), 1536-1546, 2013 | 56 | 2013 |
| Integrating murine and clinical trials with cabozantinib to understand roles of MET and VEGFR2 as targets for growth inhibition of prostate cancer A Varkaris, PG Corn, NU Parikh, E Efstathiou, JH Song, YC Lee, ... Clinical Cancer Research 22 (1), 107-121, 2016 | 51 | 2016 |
